Report an Adverse Event

Creating-Possible-Fund-HeroBanner
Report-An-Adverse-Event-PromoReport-An-Adverse-Event-Promo

Patient safety is paramount to us, and we manage safety data relating to our treatments with the utmost rigor. While Gilead continuously evaluates the safety of our treatments, it's often not possible to detect every potential side effect associated with a medicinal product during clinical trials, so it is important to continue to report safety data once a product is authorized.

Collecting safety information from patients, healthcare providers and customers helps enable us to continually monitor the benefit and risk profiles of our medicinal products.

If you have a general question about Gilead medicines, please visit the Gilead Medical Information siteExternal-icon

Please select your country from the list below for information on how to report a potential adverse event

Thank you for contacting Gilead. Patient safety is our top priority. To report an adverse event, please contact the local drug safety representative for your region as detailed on the product label.

Depending on the country you select, you will be directed to the applicable safety reporting method, either electronically or via locally established mechanisms. If online reporting is available, upon selecting your country you will be directed to the Gilead Safety Information Reporting (GSIR) tool.

Adverse Event Privacy

Gilead Sciences, Inc. and its affiliates (Gilead) are required by law to investigate safety events and may be obliged to report such incidents to the competent authorities.

Accordingly, Gilead will record the personal information provided by you, as the individual reporting the event, such as your name, contact details (email and/or postal address, phone number), and profession/speciality (if you are a healthcare professional). Gilead may use this information to contact you and seek such additional information as it may require in order to fulfill its regulatory obligations.

Gilead will process and use the personal information it records, the health and other information that you provide in relation to the safety event, as well as any additional information which it receives from you in compliance with its obligations related to safety.

Your personal information will be held for a limited period of time, sufficient to satisfy any pharmacovigilance, safety and other legal obligations that Gilead is subject to.

Gilead may share your personal data with vendors appointed by Gilead to assist it in the administration of the safety reporting, as well as with the relevant national and/or international regulatory authorities, enforcement, public bodies or courts, where Gilead is required to do so by applicable laws, regulations, or at the request of those authorities.

Where we transfer your personal data outside of the EU or your country, we'll protect and transfer it in a manner consistent with applicable data protection law.

Depending on which jurisdiction you are in, you may have certain rights and choices regarding Gilead’s processing of your personal information, such as the right to require details about the personal information that Gilead holds about you, the right of access to your personal information, the right to restrict the processing and use of your personal information and to correct and update it. If, at any time, you have questions or concerns about this Privacy Notice or the processing of your personal information, or would like to exercise your rights, you can contact Gilead at Privacy@gilead.com, or a Gilead data protection officer at: dpo@gilead.com.

For additional information on how Gilead handles personal information both online and offline, please refer to the Gilead Privacy Statement at Gilead Privacy Statement.